background image
10.11
(13)
Form of Nonqualified Stock Option Agreement, as amended*
10.12
(13)
Array BioPharma Inc. Amended and Restated Employee Stock Purchase Plan*
10.13
(30)
Employment Agreement between Registrant and Ron Squarer dated April 24,
2012*
10.14
(30)
Noncompete Agreement between Registrant and Ron Squarer dated April 24,
2012*
10.15
(30)
Confidentiality and Inventions Agreement between Registrant and Ron Squarer
dated April 24, 2012*
10.16
(5)
Form of Employment Agreement dated September 1, 2002 between Registrant
and each of David L. Snitman, Kevin Koch and R. Michael Carruthers*
10.17
(4)
Employment Agreement effective as of March 4, 2002 between Registrant and
John Moore*
10.18
(8)
Amended and Restated Deferred Compensation Plan of Array BioPharma Inc.
dated December 20, 2004*
10.19
(10)
First Amendment to the Amended and Restated Deferred Compensation Plan of
Array BioPharma Inc.*
10.20
(1)
Research Services Agreement between Registrant and Eli Lilly and Company
dated March 22, 2000, as amended**
10.21
(3)
Research Agreement between Registrant and Amgen Inc. dated as of
November 1, 2001**
10.22
(2)
Lead Generation Collaboration Agreement between Registrant and Takeda
Chemical Industries, Ltd., dated July 18, 2001**
10.23
(7)
Collaboration and License Agreement between Registrant and AstraZeneca AB,
dated December 18, 2003**
10.24
(7)
Drug Discovery Collaboration Agreement between Registrant and
Genentech, Inc., dated December 22, 2003**
10.25
(10)
Second Amendment dated October 1, 2005 to the Drug Discovery Collaboration
Agreement between Registrant and Genentech, Inc.**
10.26
(29)
Sixth Amendment to Drug Discovery Collaboration Agreement dated as of
September 30, 2010 between the Registrant and Genentech, Inc
10.27
(21)
Letter Agreement dated July 30, 2009 between the Registrant and
Genentech, Inc.**
10.28
(31)
License Agreement dated August 5, 2011 between the Registrant and
Genentech, Inc.**
10.29
(9)
Drug Discovery Collaboration Agreement between Registrant and InterMune, Inc.,
dated September 13, 2002 along with Amendment No. 1 dated May 8, 2003,
Amendment No. 2 dated January 7, 2004, Amendment No. 3 dated September 10,
2004, Amendment No. 4 dated December 7, 2004, Amendment No. 4A dated
March 10, 2005 and Amendment No. 5 dated June 30, 2005**
10.30
(13)
Amendment No. 6 dated February 3, 2006 to the Drug Discovery Collaboration
Agreement between Registrant and InterMune, Inc., dated September 13, 2002**
10.31
(13)
Amendment No. 7 dated June 28, 2006 to the Drug Discovery Collaboration
Agreement between Registrant and InterMune, Inc., dated September 13, 2002**
10.32
(12)
Exercise of Option to Extend Funding of Research FTEs dated August 31, 2006 to
the Drug Discovery Collaboration Agreement between Registrant and
InterMune, Inc., dated September 13, 2002
10.33
(10)
Drug Discovery Agreement between Registrant and Ono
Pharmaceutical Co., Ltd., dated November 1, 2005**
10.34
(16)
Drug Discovery and Development Agreement by and between Registrant and
Celgene Corporation dated September 21, 2007**
10.35
(18)
First Amendment to Drug Discovery and Development Agreement between
Registrant and Celgene Corporation dated June 17, 2009**
10.36
(33)
Second Amendment to Drug Discovery and Development Agreement between
Registrant and Celgene Corporation dated January 8, 2012**
10.37
(9)
Loan and Security agreement by and between Registrant and Comerica Bank
dated June 28, 2005
10.38
(10)
First Amendment to Loan and Security agreement by and between Registrant and
Comerica Bank dated December 19, 2005.
10.39
(12)
Second Amendment to Loan and Security Agreement between the Registrant and
Comerica Bank dated July 7, 2006
10.40
(28)
Third Amendment to Loan and Security Agreement dated June 12, 2008 between
the Registrant and Comerica Bank
10.41
(28)
Fourth Amendment to Loan and Security Agreement dated March 11, 2009
between the Registrant and Comerica Bank
10.42
(20)
Fifth Amendment to Loan and Security Agreement dated September 30, 2009
between the Registrant and Comerica Bank
10.43
(23)
Sixth Amendment to Loan and Security Agreement dated March 31, 2010
between the Registrant and Comerica Bank
10.44
(32)
Seventh Amendment to Loan and Security Agreement dated June 11, 2011
between the Registrant and Comerica Bank
10.45
(15)
Facility Agreement dated April 29, 2008 between the Registrant and Deerfield
Private Design Fund, L.P. and Deerfield Private Design International, L.P.**
10.46
(15)
Security Agreement dated April 29, 2008 between the Registrant and Deerfield
Private Design Fund, L.P. and Deerfield Private Design International, L.P.**
10.47
(18)
Letter Agreement dated May 15, 2009 amending Security Agreement dated
April 29, 2008 between the Registrant and Deerfield Private Design Fund, L.P. and
Deerfield Private Design International, L.P.
10.48
(26)
Facility Agreement dated May 15, 2009 between the Registrant and Deerfield
Private Design Fund, L.P., and Deerfield Private Design International**
10.49
(27)
Letter Agreement dated May 2, 2011 amending the Facility Agreement dated
April 28, 2008 and the Facility Agreement dated May 15, 2009 between the
Registrant and Deerfield Private Design Fund, L.P., and Deerfield Private Design
International, L.P.
10.50
(27)
Securities Purchase Agreement dated May 2, 2011 between the Registrant and
Deerfield Private Design Fund, L.P., and Deerfield Private Design
International, L.P., Deerfield Partners, L.P., and Deerfield International Limited
10.51
(12)
Facilities Lease and Assignment dated July 7, 2006 between the Registrant and
BMR-3200 Walnut Street LLC